Showing results (471-480 of 488) with videos related to

Sort By:
Pageof 49
Vaccines|January 22, 2024
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer PatientsChristopher W Dukes, Marine Potez, Jeffrey Lancet, et al.
Annals of Internal Medicine|June 16, 2025
Screening for Anal Cancer Among Men Who Have Sex With Men With HIV: Benefits, Harms, and Cost-Effectiveness AnalysesAshish A Deshmukh, Haluk Damgacioglu, Keith Sigel, et al.
Pediatrics|July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical TrialsEdson D Moreira, Stan L Block, Daron Ferris, et al.
Vaccine|July 3, 2025
Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201Anna R Giuliano, Anna Beltrame, Luisa L Villa, et al.
The Journal of Infection|May 3, 2026
Genotype Distribution of Human Papillomavirus (HPV) Types in Oral Gargle Specimens among Men Living with HIV in Mexico, Brazil, and Puerto Rico: a Cross-Sectional StudyAnna Beltrame, Anna R Giuliano, Luisa L Villa, et al.
Scientific Reports|May 29, 2026
Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trialAnna Beltrame, Luisa L Villa, Eduardo Lazcano-Ponce, et al.
Papillomavirus Research (Amsterdam, Netherlands)|July 20, 2017
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trialsLone K Petersen, Jaime Restrepo, Edson D Moreira, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 12, 2018
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public HealthScott M Lippman, Cory Abate-Shen, Karen L Colbert Maresso, et al.
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionXavier Castellsagué, Kevin A Ault, F Xavier Bosch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2014
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseElmar A Joura, Kevin A Ault, F Xavier Bosch, et al.
Pageof 49